CO4180603A1 - Procedimiento de preparacion de composiciones orales que contienen quinolonas - Google Patents

Procedimiento de preparacion de composiciones orales que contienen quinolonas

Info

Publication number
CO4180603A1
CO4180603A1 CO94047881A CO94047881A CO4180603A1 CO 4180603 A1 CO4180603 A1 CO 4180603A1 CO 94047881 A CO94047881 A CO 94047881A CO 94047881 A CO94047881 A CO 94047881A CO 4180603 A1 CO4180603 A1 CO 4180603A1
Authority
CO
Colombia
Prior art keywords
procedure
preparation
quinolonas
compositions containing
oral compositions
Prior art date
Application number
CO94047881A
Other languages
English (en)
Inventor
Gabriel Gousset
Philippe Riviere
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of CO4180603A1 publication Critical patent/CO4180603A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. UN PROCEDIMIENTO DE PREPARACION DE UNA FORMULA- CION ORAL MEJORADA DE PRINCIPIOS ACTIVOS QUE PER- TENECEN A LA CLASE DE QUINOLONAS, CARACTERIZADO EN QUE SE INTRODUCE UNA ETAPA DE COMPACTAJE Y LUEGO DE TRITURADO, PREVIAMENTE A LA COMPRESION DE LA MEZCLA DEL PRINCIPIO ACTIVO Y DE LOS EXCIPIENTES.
CO94047881A 1993-10-21 1994-10-20 Procedimiento de preparacion de composiciones orales que contienen quinolonas CO4180603A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9312550A FR2711524B1 (fr) 1993-10-21 1993-10-21 Procédé de préparation de compositions orales contenant des quinolones.

Publications (1)

Publication Number Publication Date
CO4180603A1 true CO4180603A1 (es) 1995-06-07

Family

ID=9452072

Family Applications (1)

Application Number Title Priority Date Filing Date
CO94047881A CO4180603A1 (es) 1993-10-21 1994-10-20 Procedimiento de preparacion de composiciones orales que contienen quinolonas

Country Status (29)

Country Link
US (1) US5840333A (es)
EP (1) EP0724442A1 (es)
AT (1) ATA905894A (es)
AU (1) AU7997094A (es)
BE (1) BE1007326A3 (es)
CA (1) CA2174444A1 (es)
CH (1) CH686555A5 (es)
CO (1) CO4180603A1 (es)
CZ (1) CZ113696A3 (es)
DZ (1) DZ1818A1 (es)
EE (1) EE9600050A (es)
ES (1) ES2126474B1 (es)
FI (1) FI961717A0 (es)
FR (1) FR2711524B1 (es)
GB (1) GB2297908B (es)
GR (1) GR1002181B (es)
HU (1) HUT74181A (es)
IE (1) IE940838A1 (es)
IT (1) IT1270672B (es)
MA (1) MA23331A1 (es)
NO (1) NO961429L (es)
NZ (1) NZ274874A (es)
OA (1) OA10282A (es)
PL (1) PL314005A1 (es)
SG (1) SG52202A1 (es)
SK (1) SK50596A3 (es)
TN (1) TNSN94110A1 (es)
WO (2) WO1995011023A1 (es)
ZA (1) ZA948175B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177101B1 (en) * 1998-06-11 2001-01-23 Pharmacia & Upjohn Company Delavirdine high strength tablet formulation
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
CN102499928A (zh) 2004-08-13 2012-06-20 先灵-普劳有限公司 包含抗菌素、三唑和皮质类固醇的药物制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions
JPH10175936A (ja) * 1996-12-17 1998-06-30 Kao Corp 新規アミドアミノポリカルボン酸又はその塩、及びそれを含有する洗浄剤組成物

Also Published As

Publication number Publication date
OA10282A (fr) 1997-10-07
GB9608316D0 (en) 1996-06-26
WO1995011023A1 (fr) 1995-04-27
HUT74181A (en) 1996-11-28
ZA948175B (en) 1995-06-08
NZ274874A (en) 1997-10-24
GB2297908B (en) 1997-12-10
US5840333A (en) 1998-11-24
FI961717A (fi) 1996-04-19
ES2126474B1 (es) 1999-11-16
FI961717A0 (fi) 1996-04-19
DZ1818A1 (fr) 2002-02-17
EP0724442A1 (fr) 1996-08-07
FR2711524B1 (fr) 1995-11-24
ES2126474A1 (es) 1999-03-16
CZ113696A3 (en) 1996-07-17
GB2297908A (en) 1996-08-21
SK50596A3 (en) 1997-02-05
FR2711524A1 (fr) 1995-05-05
EE9600050A (et) 1996-10-15
BE1007326A3 (fr) 1995-05-16
MA23331A1 (fr) 1995-04-01
IE940838A1 (en) 1995-05-03
NO961429D0 (no) 1996-04-11
AU7997094A (en) 1995-05-08
HU9601041D0 (en) 1996-06-28
SG52202A1 (en) 1998-09-28
CA2174444A1 (fr) 1995-04-27
GR1002181B (en) 1996-03-12
ITMI942130A0 (it) 1994-10-19
IT1270672B (it) 1997-05-07
NO961429L (no) 1996-04-11
CH686555A5 (fr) 1996-04-30
ITMI942130A1 (it) 1996-04-19
PL314005A1 (en) 1996-08-05
TNSN94110A1 (fr) 1995-09-21
ATA905894A (de) 2000-06-15
WO1995011022A1 (fr) 1995-04-27

Similar Documents

Publication Publication Date Title
PT893992E (pt) Formas de dosagem oral de desintegracao rapida
MX9703556A (es) Composicion para bloquear los rayos solares y para curar heridas.
EA200000062A1 (ru) Фармацевтические композиции, содержащие шипучую кислотно-основную пару
NZ506174A (en) Olive and parsley oils together with mint oil, menthol and chlorophyll in pharmaceutical compositions for treating halitosis
ES2154633T3 (es) Procedimiento y composicion de prevencion de la enfermedad de lyme.
AR014133A1 (es) Procedimiento para fabricar tabletas de dispersion rapida para administracion oral y una formulacion de dichas tabletas
DK1341527T3 (da) Farmaceutisk præparat omfattende et aktivstof dispergeret på en matrix
ATE200733T1 (de) Pharmazeutische zubereitungen, die fluoxetin enthalten
ES2151083T3 (es) Composiciones orales que contienen ondansetron.
LV12731A (en) Flash-melt oral dosage formulation
FI972167A (fi) Pakastekuivatut ondansetronikoostumukset
EA199900026A1 (ru) Быстрорастворимая таблетка гидробромида галантамина
AR021922A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos, budesonido y formoterol.
ES2045194T3 (es) Un procedimiento para obtener preparaciones farmaceuticas comprimidasy moldeadas.
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
PE68899A1 (es) Composicion que contiene paracetamol
ES460743A1 (es) Procedimiento para la obtencion de preparados medicinales con ph acido.
AR021921A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos y budesonido.
DE69211688T2 (de) Kaubare antacida
CO4180603A1 (es) Procedimiento de preparacion de composiciones orales que contienen quinolonas
DE69129459D1 (de) Immunosuppressive zusammensetzungen
ES2172957T3 (es) Procedimiento para la preparacion de formulaciones farmaceuticas que contienen un extracto.
UA37206C2 (uk) Фармацевтична композиція, яка містить алкілсульфонамід-агоніст 5нті- подібного рецептора для ректального введення
ES2154744T3 (es) Formulaciones de comprimidos farmaceuticos para compresion directa.
DE60103276D1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält